Results 91 to 100 of about 5,917,592 (236)

Relationship between Mesenteric and Peripheral Blood Levels of CA 19-9 in Patients with Colorectal Cancer

open access: yesThe International Journal of Biological Markers, 2001
Introduction CA19-9 is one of the most important tumor markers used in patients with colorectal cancer, mainly in radical surgery follow-up. Aim: The purpose of this study was to evaluate the preoperative CA19-9 level obtained from a peripheral vein (PV)
N. M. Forones, M. Tanaka, D. Matos
doaj   +1 more source

Serum CA19-9 levels in testicular germ cell tumor patients [PDF]

open access: yes, 2001
自治医科大学泌尿器科で経験した精巣胚細胞性腫瘍55症例において, 血清CA19-9の測定意義について検討した.治療前血清CA19-9の上昇は16.4%(Seminoma 3.0%, NSGCT 36.4%)に認められた.治療前血清CA19-9はNSGCTで有意に血清値及び陽性率が高く, 組織型では胎児性癌及び卵黄嚢腫瘍を含む症例で, 有意に血清値が高値を示した.また繊毛癌症例では陽性症例を認めなかった.血清hCG-βやAFPとcombination assayを行うことにより ...
徳江, 章彦, 鈴木, 一実
core  

Assessment of MRD and Longitudinal Monitoring of Post‐Surgery Biliary Tract Cancer With a Customized ctDNA Panel

open access: yesCancer Science, EarlyView.
A customized panel was established for BTC MRD detection. Preoperative ctDNA detection was associated with pathological stage and poorer RFS and OS. Longitudinal monitoring detected ctDNA before radiological recurrence in 72.7% of patients, with a median lead time of 77 days, supporting ctDNA as a complementary prognostic biomarker with CA19‐9 ...
Yoshihito Shinohara   +13 more
wiley   +1 more source

Levels of Markers in Plasma of CA19-9-Negative IDACP Patients.

open access: yes, 2016
Levels of Markers in Plasma of CA19-9-Negative IDACP Patients.
Takuji Okusaka (128610)   +22 more
core   +1 more source

Liquid Biopsy and Multi‐Cancer Early Detection Tests for Cancer Screening: A Scoping Review

open access: yesClinical Genetics, EarlyView.
There is a large body of evidence on liquid biopsy and multi‐cancer detection tests for cancer screening. Most studies addressed test performance outcomes, while fewer addressed clinical outcomes, implementation, and cost‐effectiveness. No studies evaluated cancer mortality.
Tessa Robinson   +6 more
wiley   +1 more source

CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer

open access: yesBMC Cancer, 2019
Background CA19–9 decrease during treatment has been associated with superior survival of pancreatic cancer in several studies. The evidence to show the correlation of high platelet level with inferior survival is insufficient in pancreatic cancer.
Y. Chen   +3 more
doaj   +1 more source

The Impact of Preoperative CA19-9 and CEA on Outcomes of Patients with Intrahepatic Cholangiocarcinoma

open access: yes, 2020
Background: The objective of the current study was to assess the impact of serum CA19-9 and CEA and their combination on survival among patients undergoing surgery for intrahepatic cholangiocarcinoma (ICC). Methods: Patients who underwent curative-intent
Amika Moro   +46 more
core   +1 more source

Computed tomography reveals multiple origins of extreme caudal vertebral pneumaticity in sauropod dinosaurs

open access: yesJournal of Anatomy, EarlyView.
Here, we present novel CT scan data of caudal vertebrae of six Middle–Late Jurassic sauropods, representing several eusauropod lineages. We synthesise these new data with a comprehensive critical appraisal of purported external and internal evidence for caudal vertebral PSP in Sauropodomorpha.
Samantha L. Beeston   +5 more
wiley   +1 more source

The Value of CA125 and CA19-9 in the Diagnosis of Stage Ⅲ and Ⅳ Endometriosis

open access: yesClinical and Experimental Obstetrics & Gynecology
Background: To evaluate the effect of carbohydrate antigen 125 (CA125) and CA19-9 in distinguishing stage Ⅲ and Ⅳ endometriosis from benign and malignant tumors, and to explore whether it is related to the clinical features of the disease.
Wenwen Zhang   +4 more
doaj   +1 more source

Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients

open access: yesFrontiers in Oncology, 2019
Background: Although Carbohydrate antigen 19-9 (CA19-9) is considered clinically useful and informative for pancreatic carcinoma (PC), false positive results, and false negative results have restricted its clinical use.
Ailing Zhong   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy